Raliplen Broker Review 2025

Raliplen is an online trading brand operating primarily via raliplen.com and raliplen.net. The .com domain was registered on 10 February 2025, while the .net domain appeared in late July 2025 — a very short web footprint for a firm that markets itself as experienced and global. The site targets an international audience in English, including the CIS region.

Key takeaways

• Unlicensed: No authorization from FCA, CySEC, ASIC, SEC/CFTC, or any reputable regulator.
  
• Official warnings: Flagged by Canadian provincial regulators (ASC, BCSC, AMF/Québec) and listed by Belgium’s FSMA in July 2025.
  
• Anonymity & inconsistencies: No disclosed legal entity; glossy claims without verifiable evidence.
  
• High-risk terms: 1:500 leverage, vague “VIP” tiers, and a white-label web terminal on a third-party domain.
  
• Complaint pattern: Blocked withdrawals, invented “fees/taxes,” pressure from “personal managers,” and aggressive solicitation.

Claimed corporate profile

• Address (claimed): 54 Fenchurch Street, London EC3M 3JY, UK.
  
• Contacts (claimed): +44 2039617102, +44 2038622925; [email protected].
  
• Social presence: No active, verifiable social media channels identified.
  

The London address is a common office-block location often cited by shell entities. There is no public evidence of genuine operations from this site and no disclosed legal entity name or registration number connected to Raliplen.

Regulation & licenses

A search across major regulatory registers shows no license of any kind for Raliplen. The firm is not authorized by the UK’s FCA or other top-tier regulators (CySEC, ASIC, NFA/CFTC, etc.). 

Conversely, multiple regulators have warned consumers:

• Alberta (ASC): Placed Raliplen on its Investment Caution List on 11 June 2025.
  
• British Columbia (BCSC): Issued a warning on 9 July 2025, stating Raliplen is not registered to trade in securities or derivatives in the province.
  
• Québec (AMF): States Raliplen is not authorized to solicit investors in the province.
  
• Belgium (FSMA): In a consolidated update on 24 July 2025, Raliplen (raliplen.com) is grouped with dozens of illegal online platforms that typically block withdrawals and operate without licenses.
  

Raliplen operates outside any reputable regulatory framework. Client funds receive no statutory protection (no compensation scheme; no recognized dispute resolution).

Trading offer at a glance

Raliplen’s marketing reads like a standard lure for newcomers:

• Minimum deposit: from $250.
  
• Leverage: up to 1:500 (far beyond legal caps in most regulated markets—e.g., 1:30 in the EU/UK for retail clients).
  
• Instruments: broad CFDs menu—crypto, stocks, indices, commodities, metals; even NFTs are mentioned. No credible liquidity providers disclosed.

• Platform: “MetaTrader” is referenced, but access is via a web terminal hosted on a third-party domain: webtrader.aternlyx.tech. This is a white-label environment widely observed among scam clusters; it allows full control over pricing/latency and can simulate fills and P&L internally.
  
• Account tiers / VIP: Multi-level “VIP” statuses with promises of tighter costs, bonuses, and privileged service. No transparent fee schedule or instrument specifications published.
  
• Education & extras: “Personal manager 24/7,” signals, copy-trading, and market “analysis.” These features primarily function as sales tools to nudge larger deposits.

Deposits & withdrawals

• Funding methods: Cards (Visa/Mastercard), bank transfer, crypto, and sometimes Apple/Google Pay intermediaries.
  
• Withdrawal reality: Numerous accounts describe a predictable pattern: small early “test” payouts (to build trust), followed by rejections, delays, or fabricated charges (15–50% “tax/fee/insurance”) once larger sums or profits are requested. These payments do not unlock the funds.
  

User feedback: recurring red flags

While some suspiciously generic five-star blurbs praise “low spreads” and “friendly support,” the overwhelming pattern in independent forums and complaint boards is consistent and damning:

1. Frozen accounts on withdrawal requests. Users report sudden blocks or KYC hurdles appearing only after asking for payouts.
   
2. Pressure from “personal managers.” Call-center “analysts” push clients to top up, promise safe or guaranteed returns (a regulatory red line), then disappear.
   
3. Invented fees. “Taxes,” “clearance fees,” “insurance deposits,” or “liquidity unlock charges” are demanded upfront; paying them rarely results in any release of funds.
   
4. Aggressive solicitation. Cold calls, email spam, lead-gen through social networks and even job sites; scripted tactics with office-noise ambience to simulate legitimacy.
   

Scam-marker checklist

Raliplen exhibits nearly all hallmarks of a boiler-room CFD scam:

• No legal entity disclosed; no company number, no audited accounts, no regulator.
  
• Brand-new domains, rapidly replaced or supplemented (.com → .net) as reputation deteriorates.
  
• White-label webtrader on a third-party host (aternlyx.tech), a telltale of scam networks that recycle the same back-end for many “brands.”
  
• Unrealistic leverage (1:500) and vague “VIP” tiers with marketing bonuses.
  
• Opaque pricing/costs: no detailed instrument specs, swaps, or stable T&Cs.
  
• Withdrawal obstruction: fabricated fees, shifting rules, and unilateral term changes.
  
• Evidence-free claims of global reach, licensing compliance, and round-the-clock expert support.
  
• Regulatory warnings already issued in multiple jurisdictions.
  

Likely links to a wider scheme

The shared infrastructure (the aternlyx.tech web terminal), recycled marketing copy, UK virtual addresses, and +44 20… phone lines strongly suggest Raliplen is one of several interchangeable labels operated by the same boiler-room apparatus. Regulators often publish group warnings, listing Raliplen alongside similarly structured sites that emerged within the same timeframe and exhibit identical behavior patterns.

Conclusion on Raliplen

Raliplen is not a legitimate broker. It is unregulated, publicly warned against by multiple authorities, and displays the full pattern of a high-risk, likely fraudulent operation: anonymity, engineered trading environment, hard-sell deposit tactics, and systematic withdrawal obstruction. There is no client-fund protection, no credible oversight, and no reason to believe profits (or even principal) are ever safely withdrawable.

Do not deposit with Raliplen. If you are researching it for an investment, treat the brand as avoid at all costs.

If you already deposited: immediate steps

1. Stop sending money and cut contact with “managers.”
   
2. Document everything (screenshots, emails, chat logs, call records, transaction receipts).
   
3. Card/bank transfer: Contact your bank immediately to request a chargeback (reason code: fraud/misrepresentation). Provide your documentation.
   
4. Crypto transfers: Record the transaction hashes; engage your local cybercrime unit and consider reputable blockchain-analytics services via law enforcement or your counsel.
   
5. File reports with your national regulator and the authorities that already issued warnings (e.g., ASC, BCSC, AMF, FSMA).
   

Beware “recovery” scams—cold callers or websites promising to get your money back for an upfront fee are almost always secondary fraud.